{
    "clinical_study": {
        "@rank": "13433", 
        "arm_group": [
            {
                "arm_group_label": "Rectal Indomethacin pre-ERCP", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive rectal indomethacin 100mg 30 minutes before procedure (ERCP)."
            }, 
            {
                "arm_group_label": "Rectal Indomethacin post-ERCP", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive rectal indomethacin 100mg immediately after procedure (ERCP)"
            }
        ], 
        "brief_summary": {
            "textblock": "To determine if the timing of administration of indomethacin affects the primary outcome of\n      post-ERCP pancreatitis (PEP). Patients undergoing ERCP will be randomly assigned to receive\n      pre or post-procedure rectal indomethacin to prevent the occurrence of PEP."
        }, 
        "brief_title": "Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)", 
        "condition": "Acute Pancreatitis", 
        "condition_browse": {
            "mesh_term": "Pancreatitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients referred for ERCP at the University of Alberta\n\n          -  Age greater than 18 years\n\n          -  Ability to provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Acute pancreatitis\n\n          -  Active peptic ulcer disease\n\n          -  Rectal disease\n\n          -  Aspirin-induced asthma\n\n          -  Nonsteroidal anti-inflammatory drug (NSAIDs) induced hypersensitivity\n\n          -  Pregnancy\n\n          -  Breast feeding\n\n          -  Creatinine clearance < 30 ml/min"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "534", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02111707", 
            "org_study_id": "Pro00041158"
        }, 
        "intervention": {
            "arm_group_label": [
                "Rectal Indomethacin pre-ERCP", 
                "Rectal Indomethacin post-ERCP"
            ], 
            "description": "Patients will receive rectal indomethacin suppository 30 minutes before or immediately after ERCP for prevention of post-procedure pancreatitis. Patients will be randomized to the timing of administration.", 
            "intervention_name": "Rectal indomethacin 100mg one time before or after ERCP", 
            "intervention_type": "Drug", 
            "other_name": "Indocid 100mg"
        }, 
        "intervention_browse": {
            "mesh_term": "Indomethacin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 9, 2014", 
        "location": {
            "contact": {
                "email": "zepedago@ualberta.ca", 
                "last_name": "Sergio Zepeda-Gomez, Assistant Professor", 
                "phone": "780-248-1578"
            }, 
            "facility": {
                "address": {
                    "city": "Edmonton", 
                    "country": "Canada", 
                    "state": "Alberta", 
                    "zip": "T6G2X8"
                }, 
                "name": "University of Alberta"
            }, 
            "investigator": [
                {
                    "last_name": "Pernilla D'Souza, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gurpal Sandha, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Richard Sultanian, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Aldo Montano-Loza, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sergio Zepeda-Gomez, M.D.", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)", 
        "overall_contact": {
            "email": "zepedago@ualberta.ca", 
            "last_name": "Sergio Zepeda-Gomez"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of Post-ERCP pancreatitis", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02111707"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "17355281", 
                "citation": "Sotoudehmanesh R, Khatibian M, Kolahdoozan S, Ainechi S, Malboosbaf R, Nouraie M. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol. 2007 May;102(5):978-83. Epub 2007 Mar 13."
            }, 
            {
                "PMID": "22494121", 
                "citation": "Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, Hayward RA, Romagnuolo J, Elta GH, Sherman S, Waljee AK, Repaka A, Atkinson MR, Cote GA, Kwon RS, McHenry L, Piraka CR, Wamsteker EJ, Watkins JL, Korsnes SJ, Schmidt SE, Turner SM, Nicholson S, Fogel EL; U.S. Cooperative for Outcomes Research in Endoscopy (USCORE). A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012 Apr 12;366(15):1414-22."
            }, 
            {
                "PMID": "12806612", 
                "citation": "Murray B, Carter R, Imrie C, Evans S, O'Suilleabhain C. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2003 Jun;124(7):1786-91."
            }, 
            {
                "PMID": "17883296", 
                "citation": "Monta\u00f1o Loza A, Rodr\u00edguez Lomel\u00ed X, Garc\u00eda Correa JE, D\u00e1valos Cobi\u00e1n C, Cervantes Guevara G, Medrano Mu\u00f1oz F, Fuentes Orozco C, Gonz\u00e1lez Ojeda A. [Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes]. Rev Esp Enferm Dig. 2007 Jun;99(6):330-6. Spanish."
            }
        ], 
        "secondary_outcome": {
            "description": "To evaluate the severity of post-ERCP pancreatitis between the 2 groups studied", 
            "measure": "Severity of Post-ERCP pancreatitis", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "source": "University of Alberta", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Alberta", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}